Type 1 diabetes: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

  NCT07222137· Eli Lilly and Company· Source

• A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  NCT07222332· Eli Lilly and Company· Source

• Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes

  NCT05854069· Vanderbilt University Medical Center· Source

• Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults and Adolescents on Top of Insulin Therapy (FABULINUS)

  NCT06111586· Sanofi· Source

• Relationship Between Insulin Dose and Complications in Type 1 Diabetes

  NCT07911033· Rachel Miller· Source

• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  NCT07784725· AstraZeneca· Source

• Closed Loop and Education for Hypoglycemia Awareness Restoration

  NCT06325202· Milton S. Hershey Medical Center· Source

• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

  NCT01793168· Sanford Health· Source

• Cholesterol Lowering and Residual Risk in Diabetes, Type 1

  NCT05641753· NYU Langone Health· Source

• Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes

  NCT06745544· Aalborg University Hospital· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 10
• Organoids 4
• Mendelian Randomization Analysis 35
• CRISPR-Cas Systems 5
• Gene Expression Profiling 34
• Sequence Analysis, RNA 3
• Whole Genome Sequencing 1
• Exome Sequencing 3
• Proteomics 20
• Metabolomics 15
• Mass Spectrometry 4
• Flow Cytometry 12
• Immunohistochemistry 16
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 33
• Machine Learning 30
• Deep Learning 10
• Cohort Studies 158
• Genome-Wide Association Study 54

• Integrative Bioinformatics Analysis Incorporating Artificial Intelligence and Machine Learning Identifies Putative Pathogenic HNF1B Missense Variants Associated with HNF1B-MODY.

  Int J Mol Sci, Oct 2026

• Artificial intelligence-driven therapeutics for disease modification in type 1 diabetes: a digital public health and clinical translation framework.

  Front Public Health, Sept 2026

• Machine learning methodology using a masked neural network for robust genetic risk score calculation from noisy and missing data.

  Brief Bioinform, Sept 2026

• Development of Insulin Bolus Calculators in Type 1 Diabetes Using a Framework Based on Real-World Data, Digital Twins and Machine Learning.

  IEEE Trans Biomed Eng, Sept 2026

• Emerging biomarkers in cardiovascular disease.

  Adv Clin Chem, Aug 2026

• A benchmarking study of feature screening approaches across type 1 diabetes omics studies classification settings.

  PLoS Comput Biol, Aug 2026

• A multi-level machine learning pipeline for prediction and prioritization of hybrid insulin peptides in type 1 diabetes.

  Front Immunol, Aug 2026

• Identification of Activity, Insulin, and Dietary Thresholds Associated With Exercise-Related Hypoglycaemia and Hyperglycaemia in Children With Type 1 Diabetes: A Free-Living Study Using Explainable Machine Learning.

  Diabetes Obes Metab, Aug 2026

• A data-driven machine learning model for effective diabetes diagnosis.

  Sci Rep, Jul 2026

• Association of Variability of Monthly Continuous Glucose Monitoring-Derived Metrics With Diabetic Kidney Disease in Type 1 Diabetes.

  Diabetes Obes Metab, Jul 2026

See which targets of this disease your abstract mentions, and go to the people working on them.